Logo image of CLSK

CLEANSPARK INC (CLSK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CLSK - US18452B2097 - Common Stock

10.91 USD
-0.49 (-4.3%)
Last: 12/26/2025, 8:00:00 PM
10.84 USD
-0.07 (-0.64%)
After Hours: 12/26/2025, 8:00:00 PM
Fundamental Rating

4

Taking everything into account, CLSK scores 4 out of 10 in our fundamental rating. CLSK was compared to 276 industry peers in the Software industry. The financial health of CLSK is average, but there are quite some concerns on its profitability. CLSK shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CLSK had positive earnings in the past year.
CLSK had a negative operating cash flow in the past year.
In the past 5 years CLSK reported 4 times negative net income.
In the past 5 years CLSK reported 4 times negative operating cash flow.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

CLSK has a Return On Assets of 11.10%. This is amongst the best in the industry. CLSK outperforms 87.41% of its industry peers.
With an excellent Return On Equity value of 16.24%, CLSK belongs to the best of the industry, outperforming 83.45% of the companies in the same industry.
Industry RankSector Rank
ROA 11.1%
ROE 16.24%
ROIC N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin of CLSK (46.11%) is better than 93.53% of its industry peers.
CLSK has a worse Gross Margin (55.23%) than 65.11% of its industry peers.
CLSK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 46.11%
GM 55.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLSK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLSK has more shares outstanding
The debt/assets ratio for CLSK is higher compared to a year ago.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.11 indicates that CLSK is not a great score, but indicates only limited risk for bankruptcy at the moment.
CLSK's Altman-Z score of 2.11 is in line compared to the rest of the industry. CLSK outperforms 51.80% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that CLSK is not too dependend on debt financing.
CLSK has a Debt to Equity ratio of 0.30. This is in the lower half of the industry: CLSK underperforms 60.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.11
ROIC/WACCN/A
WACC10.58%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 4.18 indicates that CLSK has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.18, CLSK belongs to the best of the industry, outperforming 83.45% of the companies in the same industry.
CLSK has a Quick Ratio of 4.18. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.18, CLSK belongs to the best of the industry, outperforming 83.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.18
Quick Ratio 4.18
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1242.86% over the past year.
The Revenue has grown by 102.21% in the past year. This is a very strong growth!
The Revenue has been growing by 138.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1242.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.3%
Revenue 1Y (TTM)102.21%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%150.52%

3.2 Future

The Earnings Per Share is expected to decrease by -68.41% on average over the next years. This is quite bad
The Revenue is expected to grow by 28.19% on average over the next years. This is a very strong growth
EPS Next Y-107.81%
EPS Next 2Y-41.37%
EPS Next 3Y-68.41%
EPS Next 5YN/A
Revenue Next Year13.38%
Revenue Next 2Y16.92%
Revenue Next 3Y28.19%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.61, which indicates a very decent valuation of CLSK.
87.41% of the companies in the same industry are more expensive than CLSK, based on the Price/Earnings ratio.
CLSK's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.92.
CLSK is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 11.61
Fwd PE N/A
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

93.88% of the companies in the same industry are more expensive than CLSK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.77
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

CLSK's earnings are expected to decrease with -68.41% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.37%
EPS Next 3Y-68.41%

More info and screens

0

5. Dividend

5.1 Amount

CLSK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CLEANSPARK INC

NASDAQ:CLSK (12/26/2025, 8:00:00 PM)

After market: 10.84 -0.07 (-0.64%)

10.91

-0.49 (-4.3%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-25 2025-11-25/amc
Earnings (Next)02-04 2026-02-04
Inst Owners79.36%
Inst Owner Change11.39%
Ins Owners1.75%
Ins Owner Change47.86%
Market Cap2.79B
Revenue(TTM)766.31M
Net Income(TTM)353.32M
Analysts83.16
Price Target24.94 (128.6%)
Short Float %33.06%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP3.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.11%
Min EPS beat(2)-103.04%
Max EPS beat(2)171.26%
EPS beat(4)2
Avg EPS beat(4)-59.51%
Min EPS beat(4)-403.92%
Max EPS beat(4)171.26%
EPS beat(8)4
Avg EPS beat(8)77.09%
EPS beat(12)7
Avg EPS beat(12)33.52%
EPS beat(16)7
Avg EPS beat(16)0.36%
Revenue beat(2)1
Avg Revenue beat(2)-3.32%
Min Revenue beat(2)-7.15%
Max Revenue beat(2)0.51%
Revenue beat(4)2
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-7.4%
Max Revenue beat(4)4.69%
Revenue beat(8)4
Avg Revenue beat(8)-1.12%
Revenue beat(12)4
Avg Revenue beat(12)-2.32%
Revenue beat(16)5
Avg Revenue beat(16)-3.99%
PT rev (1m)-2.45%
PT rev (3m)13.62%
EPS NQ rev (1m)-156.42%
EPS NQ rev (3m)-158.74%
EPS NY rev (1m)-108.38%
EPS NY rev (3m)-106.3%
Revenue NQ rev (1m)-17.52%
Revenue NQ rev (3m)-23.8%
Revenue NY rev (1m)-18.99%
Revenue NY rev (3m)-22.88%
Valuation
Industry RankSector Rank
PE 11.61
Fwd PE N/A
P/S 3.64
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB 1.37
EV/EBITDA 6.77
EPS(TTM)0.94
EY8.62%
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-1.8
OCFYN/A
SpS3
BVpS8.51
TBVpS7.97
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.42
Profitability
Industry RankSector Rank
ROA 11.1%
ROE 16.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 46.11%
GM 55.23%
FCFM N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 2.67
Cap/Depr 45.43%
Cap/Sales 20.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.18
Quick Ratio 4.18
Altman-Z 2.11
F-Score4
WACC10.58%
ROIC/WACCN/A
Cap/Depr(3y)67.81%
Cap/Depr(5y)346.78%
Cap/Sales(3y)33.73%
Cap/Sales(5y)94.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1242.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.3%
EPS Next Y-107.81%
EPS Next 2Y-41.37%
EPS Next 3Y-68.41%
EPS Next 5YN/A
Revenue 1Y (TTM)102.21%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%150.52%
Revenue Next Year13.38%
Revenue Next 2Y16.92%
Revenue Next 3Y28.19%
Revenue Next 5YN/A
EBIT growth 1Y-78.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-9.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-55.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.31%
OCF growth 3YN/A
OCF growth 5YN/A

CLEANSPARK INC / CLSK FAQ

What is the ChartMill fundamental rating of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CLSK.


What is the valuation status for CLSK stock?

ChartMill assigns a valuation rating of 3 / 10 to CLEANSPARK INC (CLSK). This can be considered as Overvalued.


What is the profitability of CLSK stock?

CLEANSPARK INC (CLSK) has a profitability rating of 3 / 10.


Can you provide the financial health for CLSK stock?

The financial health rating of CLEANSPARK INC (CLSK) is 4 / 10.


What is the earnings growth outlook for CLEANSPARK INC?

The Earnings per Share (EPS) of CLEANSPARK INC (CLSK) is expected to decline by -107.81% in the next year.